Health Catalyst (HCAT) Cost of Revenue (2018 - 2026)

Health Catalyst's Cost of Revenue history runs 9 years deep, the most recent figure standing at $35.3 million for Q1 2026.

• Quarterly Cost of Revenue fell 18.26% year-over-year to $35.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $151.6 million (down 11.08% YoY) and the FY2025 annual result came in at $159.5 million, down 3.83% from the prior year.
• Cost of Revenue was $35.3 million for Q1 2026 at Health Catalyst, roughly flat from $35.3 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $44.9 million in Q4 2024 and bottomed at $34.0 million in Q1 2022.
• A 5-year average of $39.3 million and a median of $38.5 million in 2024 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2022 — Cost of Revenue rose 24.35% — and 2025, when it declined 21.42%.
• Health Catalyst's Cost of Revenue stood at $38.1 million in 2022, then rose by 16.98% to $44.6 million in 2023, then grew by 0.76% to $44.9 million in 2024, then retreated by 21.42% to $35.3 million in 2025, then slipped by 0.01% to $35.3 million in 2026.
• Business Quant data shows HCAT's Cost of Revenue at $35.3 million in Q1 2026, $35.3 million in Q4 2025, and $38.5 million in Q3 2025.